These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11486158)

  • 21. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
    Tai CT; Chiang CE; Lee SH; Chen YJ; Yu WC; Feng AN; Ding YA; Chang MS; Chen SA
    J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1180-7. PubMed ID: 10517649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amiodarone: treatment or cause of atrial fibrillation?].
    Allali G; Falconnet C
    Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液).
    Deng M; Sui XQ; Zhu SB; Ma W; Xu Y; Chen ZM
    Chin J Integr Med; 2010 Oct; 16(5):453-6. PubMed ID: 20872121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amiodarone--still a useful antiarrhythmic drug].
    Gjesdal K
    Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1532-3. PubMed ID: 18587462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose amiodarone for atrial fibrillation.
    Middlekauff HR; Wiener I; Stevenson WG
    Am J Cardiol; 1993 Nov; 72(16):75F-81F. PubMed ID: 8237834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
    Hilleman DE; Spinler SA
    Pharmacotherapy; 2002 Jan; 22(1):66-74. PubMed ID: 11794432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dronedarone for atrial fibrillation: How does it compare with amiodarone?
    Penugonda N; Mohmand-Borkowski A; Burke JF
    Cleve Clin J Med; 2011 Mar; 78(3):179-85. PubMed ID: 21364162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone: an emergency medicine perspective.
    Taylor SE
    Emerg Med (Fremantle); 2002 Dec; 14(4):422-9. PubMed ID: 12534486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.
    Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D
    Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of amiodarone on autonomic status and its efficacy in the treatment of different variants of paroxysmal atrial fibrillation].
    Shabalin AV; Shaposhnikova IuS; Guseva IA
    Kardiologiia; 2002; 42(8):25-9. PubMed ID: 12494090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone plus Flecainide combination therapy in patients with Amiodarone refractory paroxysmal atrial fibrillation.
    Kagal DR; Crystal E; Lashevsky I; Tiong I; Lau C; Vitali AC; Newman D
    Int J Cardiol; 2013 Oct; 168(4):4262-3. PubMed ID: 23680597
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
    Bonora A; Turcato G; Franchi E; Taioli G; Dilda A; Zerman G; Maccagnani A; Pistorelli C; Olivieri O
    Intern Emerg Med; 2017 Sep; 12(6):853-859. PubMed ID: 27384766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
    N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dronedarone: a review of characteristics and clinical data.
    Baroletti S; Catella J; Ehle M; Cheng JW
    Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
    Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
    Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation.
    Peuhkurinen K; Niemelä M; Ylitalo A; Linnaluoto M; Lilja M; Juvonen J
    Am J Cardiol; 2000 Feb; 85(4):462-5. PubMed ID: 10728951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.